Abstract
Pharmaceutical companies’ medical information services are well established in Europe. They are responsible for providing information about a company’s medicines to health care professionals and to the company’s marketing, sales, and other staff. Although terminology, roles, and responsibilities differ from country to country (and from company to company), there are many similarities.
The aim of this article is to give a brief overview of medical information services in Europe. Although both of us are based in the United Kingdom, we have extensive contact with our colleagues in mainland Europe. Our comments are based on our own experience and on what we have learned from our colleagues.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
European Federation of Pharmaceutical Industries’ Associations. European Code of Practice for the Promotion of Medicines. Brussels: EFPIA; 1992.
Prescription Medicines Code of Practice Authority. Code of Practice for the Pharmaceutical Industry. London: Association of the British Pharmaceutical Industry; 1998.
Smith R. What clinical information do doctors need? Br Med J. 1996;313:1062–1068.
Wyatt J. Use and sources of medical knowledge. Lancet. 1991;338:1368–1373.
Stinson ER, Mueller DA. Survey of health professionals’ information habits and needs. JAMA. 1980;243:140–143.
Robson AS, Blake J, Chandler R, et al. Medical information services in the pharmaceutical industry: a survey of pharmacists’ views with recommendations. Pharmaceut J. 1996;256:864–866.
Shaughnessy AF, Slawson DC. Pharmaceutical representatives. Effective if used with caution. Br Med J. 1996;312:1494.
Association of Information Officers in the Pharmaceutical Industry. AIOPl guidelines on standards for medical information departments 1999. http://www.aiopi.org.uk
Leighton S. Drug information pharmacists survey of pharmaceutical industry medical information services. Abstract presented to the 26th UK Drug Information Conference, June 29-July 1, 2000, Cardiff, Wales.
Healy EM, Kaitin KI. The European Agency for the Evaluation of Medicinal Products’ centralized procedure for product approval: Current status. Drug Inf J. 1999;33:969–978.
Riggins JL, Ferguson KJ, Gorham E. Globalizing medical information services at Eli Lilly and Company. Drug Inf J. 1999;33:515–524.
Robson A, Bandle E, Ince J. Medinfolink: a practical approach to knowledge management at SmithKline Beecham Pharmaceuticals. In: Online Information 99, Proceedings. Oxford: Learned Information Europe Ltd; 1999: 87–191.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Robson, A.S., Robson, D. Industry-Based Medical Information in Europe: Practices and Customer Expectations. Ther Innov Regul Sci 34, 1089–1095 (2000). https://doi.org/10.1177/009286150003400414
Published:
Issue Date:
DOI: https://doi.org/10.1177/009286150003400414